$709 Million is the total value of Meditor Group Ltd's 36 reported holdings in Q3 2013. The portfolio turnover from Q2 2013 to Q3 2013 was 52.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Sell | MERCK & CO. INC. | $83,154,000 | -4.1% | 1,746,600 | -6.4% | 11.73% | -0.1% |
| ONXX | Sell | ONYX PHARMACEUTICALS INC | $54,245,000 | -35.1% | 435,000 | -54.8% | 7.65% | -32.4% |
| ALKS | Sell | ALKERMES PLC | $52,783,000 | +8.3% | 1,570,000 | -7.6% | 7.44% | +12.7% |
| HPQ | Sell | HEWLETT-PACKARD CO | $24,273,000 | -41.6% | 1,156,423 | -31.0% | 3.42% | -39.2% |
| GOOGL | Sell | GOOGLE INC-CL Acl a | $20,542,000 | -73.3% | 23,452 | -73.1% | 2.90% | -72.2% |
| ISIS | Sell | ISIS PHARMACEUTICALS INC | $18,395,000 | +31.7% | 490,000 | -5.8% | 2.59% | +37.1% |
| ITMN | Sell | INTERMUNE INC | $15,765,000 | +19.2% | 1,025,000 | -25.5% | 2.22% | +24.1% |
| AAPL | Sell | APPLE INC | $14,303,000 | -12.0% | 30,000 | -26.8% | 2.02% | -8.4% |
| MU | Sell | MICRON TECHNOLOGY INC | $2,708,000 | -18.6% | 155,000 | -33.2% | 0.38% | -15.1% |
| HAL | Sell | HALLIBURTON CO | $1,493,000 | -34.9% | 31,000 | -43.6% | 0.21% | -32.2% |
| MSFT | Exit | MICROSOFT CORP | $0 | – | -20,000 | -100.0% | -0.09% | – |
| SQNM | Exit | SEQUENOM INC | $0 | – | -700,000 | -100.0% | -0.40% | – |
| RIGL | Exit | RIGEL PHARMACEUTICALS INC | $0 | – | -900,000 | -100.0% | -0.41% | – |
| INFI | Exit | INFINITY PHARMACEUTICALS INC | $0 | – | -250,000 | -100.0% | -0.55% | – |
| NDAQ | Exit | NASDAQ OMX GROUP/THE | $0 | – | -124,793 | -100.0% | -0.55% | – |
| ECYT | Exit | ENDOCYTE INC | $0 | – | -335,000 | -100.0% | -0.60% | – |
| ALNY | Exit | ALNYLAM PHARMACEUTICALS INC | $0 | – | -144,647 | -100.0% | -0.61% | – |
| BMC | Exit | BMC SOFTWARE INC | $0 | – | -147,000 | -100.0% | -0.90% | – |
| OPTR | Exit | OPTIMER PHARMACEUTICALS INC | $0 | – | -475,000 | -100.0% | -0.93% | – |
| SFD | Exit | SMITHFIELD FOODS INC | $0 | – | -651,000 | -100.0% | -2.89% | – |
| BBRY | Exit | RESEARCH IN MOTION | $0 | – | -2,210,000 | -100.0% | -3.13% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2013-10-25
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| EXELIXIS INC | 43 | Q4 2023 | 88.9% |
| ALKERMES PLC | 31 | Q4 2020 | 62.6% |
| ISHARES MSCI INDIA ETF | 31 | Q4 2023 | 5.5% |
| WISDOMTREE INDIA EARNINGS FUND | 31 | Q4 2023 | 5.5% |
| ESPERION THERAPEUTICS INC | 27 | Q4 2023 | 34.4% |
| VIVUS INC | 15 | Q4 2016 | 21.3% |
| CELLDEX THERAPEUTICS | 14 | Q2 2020 | 2.7% |
| PROSHARES ULTRAPRO SHORT S&P500 | 4 | Q4 2017 | 3.8% |
| PROSHARES ULTRASHORT S&P500 | 4 | Q4 2017 | 3.0% |
| PROSHARES ULTRASHORT S&P 500 ETF | 3 | Q3 2019 | 0.8% |
View Meditor Group Ltd's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| EXELIXIS, INC. | April 09, 2019 | 15,001,073 | 5.0% |
| VIVUS INC | December 19, 2012 | 5,002,896 | 5.0% |
| VIVUS INC | March 21, 2012 | 6,177,500 | 6.3% |
| VION PHARMACEUTICALS INC | February 15, 2008 | 5,736,200 | 7.6% |
| CYPRESS BIOSCIENCE INC | September 26, 2007 | 1,864,645 | 5.0% |
| ONYX PHARMACEUTICALS INC | September 12, 2007 | 2,627,800 | 4.8% |
| ACUSPHERE INC | July 26, 2007 | 1,839,421 | 4.0% |
| NOVACEA INC | June 11, 2007 | 800,000 | 3.4% |
| ATHEROGENICS INC | May 02, 2007 | 1,361,800 | 3.5% |
View Meditor Group Ltd's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-04-11 |
| 13F-HR | 2024-01-04 |
| SC 13G/A | 2024-01-03 |
| 13F-HR | 2023-10-31 |
| 13F-HR | 2023-07-25 |
| 13F-HR | 2023-04-10 |
| 13F-HR | 2023-01-05 |
| SC 13G/A | 2023-01-04 |
| 13F-HR | 2022-11-07 |
| 13F-HR | 2022-07-18 |
View Meditor Group Ltd's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.